Generali Powszechne Towarzystwo Emerytalne Invests $18.04 Million in Danaher Corporation $DHR

Generali Powszechne Towarzystwo Emerytalne bought a new stake in Danaher Corporation (NYSE:DHR) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 91,000 shares of the conglomerate’s stock, valued at approximately $18,042,000. Danaher comprises about 3.5% of Generali Powszechne Towarzystwo Emerytalne’s portfolio, making the stock its 15th biggest position.

A number of other large investors have also added to or reduced their stakes in the company. WFA of San Diego LLC purchased a new position in shares of Danaher during the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new position in Danaher during the second quarter valued at approximately $27,000. TruNorth Capital Management LLC purchased a new position in shares of Danaher during the third quarter worth approximately $28,000. Red Tortoise LLC lifted its holdings in shares of Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after acquiring an additional 98 shares during the last quarter. Finally, Tripletail Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth approximately $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.8%

DHR opened at $239.83 on Friday. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The business has a 50 day simple moving average of $227.79 and a two-hundred day simple moving average of $211.58. The firm has a market capitalization of $169.40 billion, a price-to-earnings ratio of 49.45, a PEG ratio of 4.23 and a beta of 0.89.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same period last year, the company earned $1.71 EPS. The business’s quarterly revenue was up 4.4% compared to the same quarter last year. Analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a yield of 0.5%. Danaher’s dividend payout ratio is 26.39%.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. The trade was a 66.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Teri List sold 3,298 shares of the business’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares in the company, valued at $4,702,593. This represents a 13.71% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 30,248 shares of company stock valued at $6,609,663. Company insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of analyst reports. Robert W. Baird set a $247.00 target price on shares of Danaher in a research report on Wednesday, October 22nd. KeyCorp reiterated an “overweight” rating on shares of Danaher in a report on Thursday, December 18th. Barclays boosted their target price on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. TD Cowen lifted their price target on Danaher from $260.00 to $270.00 and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research report on Monday, December 29th. Twenty-one investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $250.96.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.